17 Sep 2021 Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis Member news
09 Sep 2021 Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases Member news
09 Sep 2021 ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs Member news
09 Sep 2021 Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
